From: Immersed in a reservoir of potential: amniotic fluid-derived extracellular vesicles
Isolated EV population (as mentioned in the study) | Source of cells | Cell culture media for EV isolation | Culture conditions | Culture time for EV isolation (hours) | Initial spins/preparations | EV isolating spin/method |
---|---|---|---|---|---|---|
Exosomes [46] | Aspiration through amniotic sac (primary murine AFSC) | MEM-α | 37 °C, 5% CO2 | 48 | i) 2000g, 20 min ii) Filtration through 0.22 μm filter | Commercial EV isolation Kit |
EVs [47] | Amniocentesis (primary human AFSC) | Sterile phosphate-buffered saline | 37 °C, 5% CO2 | 24 | i) 300g, 5 min ii) 2000g, 20 min | 200,000g, duration not specified |
EVs [48] | Amniocentesis (primary human AFSC) | αMEM with 15% FBS, 1% l-glutamine, 1% penicillin/streptomycin, 18% Chang B and 2% Chang C | 37 °C, 5% CO2, 1% O2 and (hypoxia) | 24 | i) 3000g, 20 min ii) 10,000g, 15 min | 100,000g, 70 min |
Exosomes [49] | Not specified (primary human AFSC) | IDMEM with exosome-free FBS, 100 μg/mL streptomycin/penicillin, 2 mM l-glutamine, 5 ng/mL basic fibroblast growth factor 2 | 37 °C, 5% CO2 | 72 | i) 200g, 5 min ii) 200g, 10 min iii) 16,500g, 30 min | 120,000g, 90 min |
Amniocentesis (primary human AFSC) | FBS free α-MEM with 2 mM l-glutamine, 100 U/ml penicillin/streptomycin | Not specified | 96 | Concentrating using centrifugal filter unit with 3 K cut-off | Commercial EV isolation Kit | |
Exosomes [51] | Not specified (cryopreserved murine AFSC) | Serum free MEM-α with 1% penicillin/streptomycin/amphotericin B | Not specified | 48 | i) 300g, 10 min ii) 2000g, 10 min iii) 10,000g, 30 min | 100,000g, 70 min |
EVs [52] | Aspiration through amniotic sac (primary murine AFSC) | Serum free α-MEM with 20% Chang medium C, 1% penicillin/streptomycin | 37 °C, 5% CO2 | 24 |  | Commercial EV isolation Kit |
Exosomes [56] | Amniocentesis (primary human AFSC) | FBS free α-MEM with 2 mM l-glutamine, 100 units/mL penicillin/streptomycin | 37 °C, 5% CO2 | 96 | Concentration using a 3 KDa cut-off filter | Commercial EV isolation Kit |
Exosomes [58] | Amniocentesis (primary human AFSC) | FBS free α-MEM with 2 mM l-glutamine, 100 U/mL penicillin/streptomycin | 37 °C, 5% CO2 | 96 | i) 300g, 10 min ii) 10,000g, 30 min | 100,000g, 1.5 h |
Exosomes [59] | Amniocentesis (primary human AFSC) | DMEM: F12 (1:1) with 10 ng/mL bFGF, 10 ng/mL EGF, 10% fetal bovine serum, and 2 mM l-glutamine | 37 °C, 5% CO2 | Not specified | i) 500g, 10 min ii) 16,500g, 20 min iii) 0.22 μm filtration | 118,000g, 70 min |
Small EVs [60] | Not specified (primary human AFSC) | Serum free DMEM with 25 mM glucose, 4 mM GlutaMAX, 50 units/mL penicillin/streptomycin | 37 °C, 5% CO2 | 24 or 48 | i) 300g, 10 min ii) 10,000g, 40 min iii) Concentration using a 30 kDa filter | Commercial EV isolation Kit |
Amniocentesis (primary human AFSC) | Serum free MSCBM with l-glutamine, gentamicin sulphate/amphotericin B | Not specified | Not specified | i) 300g, 10Â min ii) 2000g, 20Â min iii) 10,000g, 30Â min | 100,000g, 1Â h | |
EVs [62] | Amniocentesis (primary human AFSC) | DMEM with 10% exosome depleted FBS | Not specified | 72 | Ultracentrifugation: 10,000g, 45 min PEG: Conditioned media mixed 1:1 with PEG 2000, 12 h, 4 °C | Ultracentrifugation: 100,000g, 70 min PEG: 10,000g, 20 min |
Amniocentesis and caesarean section (primary human AFSC) | Serum free DMEM with 1% l-glutamine and 1% penicillin/streptomycin | 37 °C, 5% CO2, 20% O2 (normoxia) or 37 °C, 5% CO2, 1% O2 and (hypoxia) | 24 | i) 300g, 10 min ii) 2000g, 20 min iii) Concentrating using a 3 kDa cut-off filter iv) 10,000g, 40 min | i) 100,000g, 2 h ii) Filtration through a 0.22 µm pore filter | |
Amniocentesis (primary human AFSC) | α-MEM with 7.5% exosome, depleted FBS | 37 °C, 5% CO2 | 18 | i) 300g, 10 min ii) 1200g, 10 min | 100,000g, 14 h | |
Nanovesicles [75] | Amniocentesis (primary human AFSC) | Serum free MSCBM medium | Not specified | Not specified | i) 300g, 10Â min ii) 2000g, 20Â min iii) 10,000g, 30Â min | 100,000g, 1Â h |
Exosomes [76] | Amniocentesis (cryopreserved human AFSC) | Serum free DMEM with penicillin/streptomycin | 37 °C, 5% CO2 | 24 | 2000g, 10 min | High speed, 1 h |
EVs [80] | Amniocentesis (cryopreserved human AFSC) | DMEM with 10% EV depleted FBS, 1% glutamine, 1% antibiotics | 37 °C, 5% CO2 | Not specified | i) 800g, 30 min ii) 16,000g, 45 min | i) 100,000g, 2 h ii) Sucrose gradient centrifugation 100,000g, 16 h |
Aspiration through amniotic sac (primary murine AFSC) | α-MEM with 7.5% exosome-depleted FBS | 37 °C, 5% CO2 | 18 | i) 300g, 10 min ii) 1200g, 10 min | 100,000g, 14 h | |
Exosomes [102] | Amniocentesis (primary human AFSC) | DMEM with 0.5% exosome-depleted FBS | 37 °C, 5% CO2 | 48 | i) 1000g, 5 min ii) 3225g, 15 min iii) Concentrating using a 3 KDa cut-off filter | 37,500 rpm, 2 h |
Exosomes [104] | Amniocentesis (primary human AFSC) | 10% exosome free FBS DMEM | 37 °C, 5% CO2 | 48 | i) 2000g, 10 min ii) 10,000g, 30 min | 100,000g, 70 min |
Exosomes [105] | Amniocentesis (primary human AFSC) | Not specified | 37 °C, 5% CO2 | Not specified | i) 300g, time not specified ii) 1000g, 5 min iii) 10,000g, 10 min iv) 0.1 μm filtration | 100,000g, 1 h |
Microvesicles [115] | Not specified (cryopreserved human AFSC) | DMEM with 15–20% FBS, 1% penicillin/streptomycin | Not specified | Not specified | 300g, 5 min | 100,000g, 2 h |
EVs [126] | Amniocentesis (primary human AFSC) | Serum free MEM-α with 1% l-glutamine and 1% penicillin/streptomycin | 37 °C, 5% CO2, 20% O2 (normoxic) or 37 °C, 5% CO2, 1% O2 and (hypoxic) | 24 | i) 3000g, 20 min ii) 10,000g, 15 min | 100,000g, 70 min |
EVs [127] | Aspiration through amniotic sac (cryopreserved murine AFSC) | Serum free RPMI-1640 | Not specified | Overnight | 6000g, 20Â min | 100,000g, 2Â h |
EVs [128] | Aspiration through amniotic sac (primary murine AFSC) | Serum free DMEM minimum essential medium with 100 IU/mL penicillin/streptomycin | 37 °C, 5% CO2 | 48 | i) 300g, 5 min ii) 16,500g, 40 min iii) Filter through 0.22 μm | 120,000g, 70 min |
EVs [100] | Not specified (cryopreserved human AFSC) | FBS free α-MEM | 37 °C, 5% CO2 | 24 | i) 180g, 5 min ii) 1000g, 10 min iii) 2000g, 10 min iv) Filter through 0.22 μm | 100,000g, 16 h |
Exosomes [129] | Caesarean section (primary human AFSC) | 10% exosome free FBS supplemented media | 37 °C, 5% CO2 | 48 | i) 3000g, 15 min ii) 13,000g, 30 min | 100,000g, 60 min/commercial EV isolation Kit (unclear) |
EVs [103] | Amniocentesis (primary human AFSC) | FBS free α-MEM with 2 mM l-glutamine, 100 U/mL penicillin/streptomycin | 37 °C, 5% CO2 | 96 | i) 300g, 10 min ii) 10,000g, 30 min | 100,000g, 1.5 h |
Exosomes [101] | Not specified (cryopreserved human AFSC) | CHANG Amnio (Irvine) culture medium supplemented with 10% exosome-depleted FBS and 1% penicillin/streptomycin | 37 °C, 5% CO2 | 24–48 | i) 750g, 5 min ii) 1500g, 5 min iii) 14,000g, 35 min | i) 110,000g, 2 h ii) 0.22 μm filtration |